Article
Multidisciplinary Sciences
Dominika Domokos, Andras Szabo, Gyongyver Banhegyi, Laszlo Major, Robert Gabor Kiss, David Becker, Istvan Ferenc Edes, Zoltan Ruzsa, Bela Merkely, Istvan Hizoh
Summary: The study suggests that the use of intravenous morphine may have no impact on long-term mortality and predischarge ejection fraction in ST-segment elevation myocardial infarction (STEMI) patients treated with primary PCI.
Article
Cardiac & Cardiovascular Systems
Krishnaraj S. Rathod, Katrina Comer, Oliver Casey-Gillman, Lizzie Moore, Gordon Mills, Gordon Ferguson, Sotiris Antoniou, Riyaz Patel, Sadeer Fhadil, Tasleem Damani, Paul Wright, Mick Ozkor, Debashish Das, Oliver P. Guttmann, Andreas Baumbach, R. Andrew Archbold, Andrew Wragg, Ajay K. Jain, Fizzah A. Choudry, Anthony Mathur, Daniel A. Jones
Summary: This study demonstrated the safety and feasibility of early hospital discharge for low-risk STEMI patients following successful primary PCI. The structured, multidisciplinary virtual follow-up schedule supported pathway helped achieve a favorable outcome with low cardiovascular mortality and MACE rates compared to a control group of patients who stayed in the hospital for >48 hours.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2021)
Article
Emergency Medicine
Xuhe Gong, Li Zhou, Tianhui Dong, Xiaosong Ding, Huiqiang Zhao, Hui Chen, Hongwei Li
Summary: The COVID-19 pandemic has affected the emergency treatment of patients with ST-segment elevation myocardial infarction (STEMI), resulting in longer symptom-to-first medical contact and door-to-balloon times. However, the pandemic is not independently associated with in-hospital major adverse cardiac events among patients undergoing primary PCI.
AMERICAN JOURNAL OF EMERGENCY MEDICINE
(2022)
Article
Medicine, General & Internal
Xiangming Hu, Xing Yang, Xida Li, Guang Li, Yingling Zhou, Haojian Dong
Summary: Elevated serum uric acid is associated with a higher incidence of no/slow-reflow phenomenon in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, especially in those with delayed perfusion or diabetes mellitus. It is related to severe inflammation and worse left ventricular ejection fraction.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
(2022)
Article
Cardiac & Cardiovascular Systems
Enrico Fabris, Sara Menzio, Caterina Gregorio, Andrea Pezzato, Davide Stolfo, Aneta Aleksova, Giancarlo Vitrella, Serena Rakar, Andrea Perkan, Arnoud W. J. Van't Hof, Gianfranco Sinagra
Summary: This study investigates the timing of antithrombotic therapy administration in ST-elevation myocardial infarction (STEMI) patients. The results show that early pretreatment strategy leads to improved basal reperfusion, reduced infarct size, and higher left ventricular ejection fraction at discharge. This highlights the importance of efficient treatment strategies for STEMI patients.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
(2022)
Article
Medicine, General & Internal
Andras Mester, Nora Rat, Theodora Benedek, Diana Opincariu, Roxana Hodas, Monica Chitu, Imre Benedek
Summary: This study investigated the relationship between acute inflammatory response and the extent of myocardial scarring as measured by CMR in STEMI patients. The results showed that IL-6 and day-5 hs-CRP levels can predict the size and transmurality of the scar, and day-5 hs-CRP levels are independent predictors of 2-year mortality. The CMR pattern of myocardial scarring after revascularization is a significant predictor for 2-year mortality in STEMI patients.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Yue Zhang, Hui Gao, Lei Liu, Shengyu Li, Bing Hua, Dihui Lan, Yi He, Jinshui Li, Hui Chen, Weiping Li, Hongwei Li
Summary: This study investigated the effectiveness of Treg, pCKMB, hsCRP, and LVESD as predictors for IMH in STEMI patients received PPCI. It found that these biomarkers can effectively predict the presence of IMH.
REVIEWS IN CARDIOVASCULAR MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
David Adlam, Maciej Zarebinski, Neal G. Uren, Pawel Ptaszynski, Keith G. Oldroyd, Shahzad Munir, Azfar Zaman, Hussain Contractor, Robert Gabor Kiss, Istvan Edes, Joanna Szachniewicz, Gergely Gyorgy Nagy, Mario J. Garcia, Janos Tomcsanyi, John Irving, Andrew S. P. Sharp, Piotr Musialek, Geza Lupkovics, Cheerag Shirodaria, Joseph B. Selvanayagam, Pauline Quinn, Leong Ng, Mark Roth, Michael A. Insko, Ben Haber, Stephen Hill, Lori Siegel, Simon Tulloch, Keith M. Channon
Summary: The study showed that giving FDY-5301 prior to PPCI in first-time STEMI patients increased plasma iodide levels and reduced myocardial damage in some patients after infarction, while also being safe and feasible.
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2022)
Review
Cardiac & Cardiovascular Systems
Rosanne F. Vogel, Ronak Delewi, Lina Badimon, Dominick J. Angiolillo, Georgios J. Vlachojannis
Summary: Since the early 20th century, the treatment of myocardial infarction has evolved extensively, including mechanical revascularization therapies and pharmacological therapies. Currently, antiplatelet therapy and anticoagulation therapy are the mainstay of pharmacological treatment. Despite the availability of several drugs, the search for novel potent agents continues to balance treatment efficacy and safety.
REVIEWS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Medicine, General & Internal
Reut Schvartz, Lior Lupu, Shir Frydman, Shmuel Banai, Yacov Shacham, Amir Gal-Oz
Summary: This study investigated the relationship between AKI and mortality in STEMI patients after PCI, and found that AKI is a significant risk factor for mortality while higher BMI has a protective effect on survival.
JOURNAL OF CLINICAL MEDICINE
(2022)
Review
Cardiac & Cardiovascular Systems
Motasem Alyamani, Sandra Campbell, Eliano Navarese, Robert C. Welsh, Kevin R. Bainey
Summary: Meta-analysis of studies suggests that targeted intracoronary thrombolytic therapy as an adjunct to primary percutaneous coronary intervention may be safe and potentially effective in improving complete ST-segment resolution and reducing in-hospital major adverse cardiac events, with no significant difference in bleeding outcomes. Further validation in larger randomized controlled trials is needed.
CANADIAN JOURNAL OF CARDIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Yu Qi, Rong Gu, Jiamin Xu, Lina Kang, Yihai Liu, Lian Wang, Jianzhou Chen, Jingmei Zhang, Kun Wang
Summary: The study found that IMR is correlated with perfusion grade and ST-segment resolution, with patients with high IMR having significantly lower LVEF at 3 months and 1 year compared to those with low IMR. IMR is negatively correlated with LVEF.
BMC CARDIOVASCULAR DISORDERS
(2021)
Article
Immunology
Xiaoxiao Zhao, Li Song, Ying Wang, Jiannan Li, Jinying Zhou, Runzhen Chen, Chen Liu, Peng Zhou, Zhaoxue Sheng, Yi Chen, Hanjun Zhao, Hongbing Yan
Summary: This prospective study aimed to determine the prognostic value of combined measures of plasma PCSK9 and PTX3 in STEMI patients undergoing primary PCI. The study found that elevated levels of both PCSK9 and PTX3 were associated with an increased risk of MACE, particularly among patients with plaque erosion.
JOURNAL OF INFLAMMATION RESEARCH
(2021)
Review
Cardiac & Cardiovascular Systems
Enrico Fabris, Abi Selvarajah, Annerieke Tavenier, Rik Hermanides, Elvin Kedhi, Gianfranco Sinagra, Arnoud Van't Hof
Summary: Antithrombotic therapy is crucial for primary PCI, but acute management of STEMI patients involves pain relief and cardioprotection. Recent evidence questions the safety and efficacy of some commonly used treatments, and additional strategies have shown disappointing results.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS
(2022)
Article
Cardiac & Cardiovascular Systems
Li Song, Xiaoxiao Zhao, Runzhen Chen, Jiannan Li, Jinying Zhou, Chen Liu, Peng Zhou, Ying Wang, Yi Chen, Hanjun Zhao, Hongbing Yan
Summary: This study found that high PCSK9 levels were independently associated with major adverse cardiovascular events (MACEs) in ST-segment elevation myocardial infarction (STEMI) patients with diabetes undergoing primary percutaneous coronary intervention (PCI). This association may be due to the stronger correlations between PCSK9 and inflammation and platelet activation markers in diabetic patients.
CARDIOVASCULAR DIABETOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Gennaro Giustino, Usman Baber, Ioannis Mastoris, Georgios J. Vlachojannis, Jennifer Yu, Paul S. Teirstein, William E. Downey, Wayne B. Batchelor, Peter J. Casterella, Eugenia Nikolsky, S. Chiu Wong, Kleanthis N. Theodoropoulos, George D. Dangas, Roxana Mehran
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
(2016)
Article
Cardiac & Cardiovascular Systems
Jennifer Yu, Roxana Mehran, Tim Clayton, C. Michael Gibson, Bruce R. Brodie, Bernhard Witzenbichler, A. Michael Lincoff, Efthymios N. Deliargyris, Bernard J. Gersh, Stuart J. Pocock, Gregg W. Stone, George D. Dangas
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
(2016)
Article
Cardiac & Cardiovascular Systems
Mikkel M. Schoos, Roxana Mehran, George D. Dangas, Jennifer Yu, Usman Baber, Peter Clemmensen, Frederick Feit, Bernard J. Gersh, Giulio Guagliumi, E. Magnus Ohman, Stuart J. Pocock, Bernhard Witzenbichler, Gregg W. Stone
AMERICAN JOURNAL OF CARDIOLOGY
(2016)
Article
Cardiac & Cardiovascular Systems
Mikkel M. Schoos, George D. Dangas, Roxana Mehran, Ajay J. Kirtane, Jennifer Yu, Claire Litherland, Peter Clemmensen, Thomas D. Stuckey, Bernhard Witzenbichler, Giora Weisz, Michael J. Rinaldi, Franz-Josef Neumann, D. Christopher Metzger, Timothy D. Henry, David A. Cox, Peter L. Duffy, Bruce R. Brodie, Ernest L. Mazzaferri, Akiko Maehara, Gregg W. Stone
AMERICAN JOURNAL OF CARDIOLOGY
(2016)
Article
Cardiac & Cardiovascular Systems
Jennifer Yu, Usman Baber, Ioannis Mastoris, George Dangas, Samantha Sartori, Philippe Gabriel Steg, David J. Cohen, Gennaro Giustino, Jaya Chandrasekhar, Cono Ariti, Bernhard Witzenbichler, Timothy D. Henry, Annapoorna S. Kini, Mitchell W. Krucoff, C. Michael Gibson, Alaide Chieffo, David J. Moliterno, Antonio Colombo, Stuart Pocock, Roxana Mehran
JACC-CARDIOVASCULAR INTERVENTIONS
(2016)
Article
Cardiac & Cardiovascular Systems
Peiren Shan, Gary S. Mintz, Bernhard Witzenbichler, D. Christopher Metzger, Michael J. Rinaldi, Peter L. Duffy, Giora Weisz, Thomas D. Stuckey, Bruce R. Brodie, Philippe Genereux, Aaron Crowley, Ajay J. Kirtane, Gregg W. Stone, Akiko Maehara
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2017)
Article
Cardiac & Cardiovascular Systems
Philippe Genereux, Bjorn Redfors, Bernhard Witzenbichler, Marie-Pier Arsenault, Giora Weisz, Thomas D. Stuckey, Michael J. Rinaldi, Franz-Josef Neumann, D. Christopher Metzger, Timothy D. Henry, David A. Cox, Peter L. Duffy, Ernest L. Mazzaferri, Dominic P. Francese, Guillaume Marquis-Gravel, Gary S. Mintz, Ajay J. Kirtane, Akiko Maehara, Roxana Mehran, Gregg W. Stone
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2017)
Article
Cardiac & Cardiovascular Systems
Kleanthis Theodoropoulos, Marco G. Mennuni, Samantha Sartori, Omar A. Meelu, Jennifer Yu, Usman Baber, Giulio G. Stefanini, Ioannis Mastoris, Pedro Moreno, George D. Dangas, Roxana Mehran, Samin K. Sharma, Annapoorna S. Kini
Review
Cardiac & Cardiovascular Systems
Michael A. Wewege, Dohee Ahn, Jennifer Yu, Kevin Liou, Andrew Keech
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2018)
Review
Health Care Sciences & Services
Praveen Indraratna, Daniel Tardo, Jennifer Yu, Kim Delbaere, Matthew Brodie, Nigel Lovell, Sze-Yuan Ooi
JMIR MHEALTH AND UHEALTH
(2020)
Article
Cardiac & Cardiovascular Systems
Gjin Ndrepepa, Franz-Josef Neumann, Maurizio Menichelli, Isabell Bernlochner, Gert Richardt, Jochen Woehrle, Bernhard Witzenbichler, Katharina Mayer, Salvatore Cassese, Senta Gewalt, Erion Xhepa, Sebastian Kufner, Hendrik B. Sager, Michael Joner, Tareq Ibrahim, Karl-Ludwig Laugwitz, Heribert Schunkert, Stefanie Schuepke, Adnan Kastrati
Summary: Patients recruited in a low recruitment center (LRC) for acute coronary syndrome appear to have more favorable cardiovascular risk profiles and lower 1-year mortality rates compared with those recruited in a high recruitment center (HRC). The recruitment volume did not interact with the treatment effect of ticagrelor versus prasugrel.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2021)
Article
Cardiac & Cardiovascular Systems
Shqipdona Lahu, Gjin Ndrepepa, Franz-Josef Neumann, Maurizio Menichelli, Isabell Bernlochner, Gert Richardt, Jochen Wohrle, Bernhard Witzenbichler, Rayyan Hemetsberger, Katharina Mayer, Ibrahim Akin, Salvatore Cassese, Senta Gewalt, Erion Xhepa, Sebastian Kufner, Christian Valina, Hendrik B. Sager, Michael Joner, Tareq Ibrahim, Karl-Ludwig Laugwitz, Heribert Schunkert, Stefanie Schupke, Adnan Kastrati
Summary: Pre-admission treatment with aspirin and/or clopidogrel does not affect the efficacy and safety of ticagrelor and prasugrel in patients with acute coronary syndromes.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
(2022)
Article
Cardiac & Cardiovascular Systems
Shqipdona Lahu, Antonia Presch, Gjin Ndrepepa, Maurizio Menichelli, Christian Valina, Rayyan Hemetsberger, Bernhard Witzenbichler, Isabell Bernlochner, Michael Joner, Erion Xhepa, Alexander Hapfelmeier, Sebastian Kufner, Nonglag Rifatov, Hendrik B. Sager, Katharina Mayer, Thorsten Kessler, Karl-Ludwig Laugwitz, Gert Richardt, Heribert Schunkert, Franz-Josef Neumann, Dirk Sibbing, Dominick J. Angiolillo, Adnan Kastrati, Salvatore Cassese
Summary: This study aimed to compare the efficacy and safety of ticagrelor and prasugrel in acute coronary syndrome patients with high bleeding risk undergoing percutaneous coronary intervention. The results showed that HBR status increased the risk of ischemic and bleeding events in these patients, but there was no significant difference in the treatment effect between ticagrelor and prasugrel. Further studies are needed for confirmation.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS
(2022)
Article
Cardiac & Cardiovascular Systems
Shqipdona Lahu, Maria Scalamogna, Gjin Ndrepepa, Maurizio Menichelli, Christian Valina, Rayyan Hemetsberger, Bernhard Witzenbichler, Isabell Bernlochner, Michael Joner, Erion Xhepa, Alexander Hapfelmeier, Sebastian Kufner, Hendrik B. Sager, Katharina Mayer, Thorsten Kessler, Karl-Ludwig Laugwitz, Gert Richardt, Heribert Schunkert, Franz-Josef Neumann, Adnan Kastrati, Salvatore Cassese
Summary: This study compares the efficacy and safety of ticagrelor and prasugrel in patients with acute coronary syndrome and prior myocardial infarction (MI). The results show that prasugrel is superior to ticagrelor in reducing the risk of recurrent ischemic events without increasing the risk of bleeding.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2022)
Article
Cardiac & Cardiovascular Systems
Bahira Shahim, Bjorn Redfors, Thomas D. Stuckey, Mengdan Liu, Zhipeng Zhou, Bernhard Witzenbichler, Giora Weisz, Michael J. Rinaldi, Franz-Josef Neumann, D. Christopher Metzger, Timothy D. Henry, David A. Cox, Peter L. Duffy, Bruce R. Brodie, Iva Srdanovic, Mahesh Madhavan, Ernest L. Mazzaferri, Roxana Mehran, Ori Ben-Yehuda, Ajay J. Kirtane, Gregg W. Stone
Summary: Diabetes mellitus and high platelet reactivity (HPR) are both associated with increased risk of ischemic events after percutaneous coronary intervention. However, it is unknown whether the HPR-related risk of adverse ischemic events differs according to diabetes mellitus status.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)